DRI Capital to float pharma royalties fund in London
Canada’s DRI Capital is preparing to list a new fund on the London Stock Exchange focused on investing in pharmaceuticals royalties.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: